Safety and efficacy of enzyme replacement therapy with agalsidase beta: an international, open-label study in pediatric patients with Fabry disease (Q40424319)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Safety and efficacy of enzyme replacement therapy with agalsidase beta: an international, open-label study in pediatric patients with Fabry disease |
scientific article |
Statements
1 reference
Safety and efficacy of enzyme replacement therapy with agalsidase beta: an international, open-label study in pediatric patients with Fabry disease (English)
1 reference
Anna Tylki-Szymanska
1 reference
J Edmond Wraith
1 reference
Nathalie Guffon
1 reference
Y Howard Lien
1 reference
Michel Tsimaratos
1 reference
Ashok Vellodi
1 reference
Dominique P Germain
1 reference
3 December 2007
1 reference
1 reference
Identifiers
1 reference